°×С½ãÂÛ̳

The objective of this programme is to provide an innovative approach to basic and translational science, drug discovery and therapeutic strategies, incorporating cross institutional and industrial pharma based training. Students will benefit from a secondment in industry at UCB, in addition to training and transferable skills courses through °×С½ãÂÛ̳ and QMUL.Ìý

PhD applications are invited for the following three projects:Ìý

1) I
Supervisors: Dr Oliver Pearce and Professor Fran Balkwill, Barts Cancer Institute, QMUL

2)Ìý
Supervisor: Dr Markella Ponticos and Professor Justin Hsuan, °×С½ãÂÛ̳

3)Ìý
Supervisors: Professor Robert Kleta and Dr Jill Norman, °×С½ãÂÛ̳

Applicants should have a good honours degree (minimum 2(i) or equivalent) with a strong background in biomedical science.

The studentship is fully funded for three years and will commence on 2 October 2017. It includes tuition fees and the student will receive a minimum tax free stipend per annum of £20000, increasing by 3% every year. The studentship is open to all nationalities, however is subject to university admissions requirements for PhD study.

Informal queries may be made to Annabelle ScottÌýa.n.scott@qmul.ac.uk.ÌýPlease direct any project related questions to the relevant Supervisor (listed above).Ìý

How to apply: Please send a covering letter and CV toÌýa.n.scott@qmul.ac.ukÌýindicating the project you would like to apply for.Ìý

Deadline for applications:Ìý1 July 2017. Interviews will be held in the middle of July 2017.